Suppr超能文献

结核病信息学资源——迈向药物发现。

Informatics resources for tuberculosis--towards drug discovery.

机构信息

ICMR-Biomedical Informatics Centre, Tuberculosis Research Centre (ICMR), Chennai 600031, India.

出版信息

Tuberculosis (Edinb). 2012 Mar;92(2):133-8. doi: 10.1016/j.tube.2011.08.006. Epub 2011 Sep 22.

Abstract

Integration of biological data on gene sequence, genome annotation, gene expression, metabolic pathways, protein structure, drug target prioritization and selection, has resulted in several online bioinformatics databases and tools for Mycobacterium tuberculosis. Alongside there has been a growth in the list of cheminformatics databases for small molecules and tools to facilitate drug discovery. In spite of these efforts there is a noticeable lag in the drug discovery process which is an urgent need in the case of emerging and re-emerging infectious diseases. For example, more than 25 online databases are available freely for tuberculosis and yet these resources have not been exploited optimally. Informatics-centered drug discovery based on the integration and analysis of both bioinformatics and cheminformatics data could fill in the gap and help to accelerate the process of drug discovery. This article aims to review the current standing of developments in tuberculosis-bioinformatics and highlight areas where integration of existing resources could lead to acceleration of drug discovery against tuberculosis. Such an approach could be adapted for other diseases as well.

摘要

生物信息学数据库和工具的发展及其在结核分枝杆菌药物研发中的应用

整合基因序列、基因组注释、基因表达、代谢途径、蛋白质结构、药物靶点优先级和选择等生物数据,已经产生了几个用于结核分枝杆菌的在线生物信息学数据库和工具。与此同时,小分子的化学信息学数据库和工具的数量也在不断增加,以促进药物发现。尽管做出了这些努力,但药物发现过程仍然明显滞后,在新发和再发传染病的情况下,这是一个迫切需要解决的问题。例如,有 25 个以上的在线数据库可免费用于结核病,但这些资源尚未得到最佳利用。基于生物信息学和化学信息学数据的整合和分析的以信息学为中心的药物发现,可以填补这一空白,并有助于加速药物发现的进程。本文旨在综述结核分枝杆菌生物信息学的最新进展,并强调整合现有资源可以加速结核病药物研发的领域。这种方法也可以适应其他疾病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验